|
OLMA Olema Pharmaceuticals Inc 1750284 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-53,089,000.00 |
| Balance Sheet |
|
Current Assets
|
$513,229,000.00 |
|
Assets
|
$530,645,000.00 |
|
Current Liabilities
|
$47,167,000.00 |
|
Liabilities
|
$50,167,000.00 |
|
Equity
|
$480,478,000.00 |
|
Shares Out
|
87332971.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-45,987,000.00 |
|
Investing Cash Flow
|
$4,529,000.00 |
| Market Analysis |
Market Cap
|
$1,032,275,717.22 |
|
Price
|
$11.28 |
|
BVPS
|
5.50 |
|
PB
|
2.15 |
|
EPS
|
-0.52 |
|
FCF
|
$-45,987,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:26 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:22 |
|
| Apr |
May |
Jun |
| 2026-03-16 |
-0.50 |
|
|
2026-05-12 |
-0.52 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-11 |
-0.51 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-10 |
-0.49 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view OLMA documents filed with the SEC.
OLMA Filings
Clear
